Unjha Formulations Ltd (531762) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531762 | NSE: | Pharmaceuticals & Drugs | Small Cap

Unjha Formulations Share Price

24.98 -0.21 -0.83%
as on 05-Dec'25 12:11

Unjha Formulations Ltd (531762) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531762 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Unjha Formulations

Based on:

M-Cap below 100cr DeciZen not available

Unjha Formulations stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
11.01
Market Cap:
11.3 Cr.
52-wk low:
20
52-wk high:
35.2

Is Unjha Formulations Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Unjha Formulations: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Unjha Formulations Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 73.7%67.6%32.2%25.4%25.6%26.8%21.1%16.8%19.5%18.1%-
Value Creation
Index
4.33.81.30.80.80.90.50.20.40.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 10.412.211.311.410.61014.213.218.513.914
Sales YoY Gr.-18%-7.7%1.1%-7.2%-6%42.2%-7.1%40.7%-25.1%-
Adj EPS 0.60.70.60.70.7-00.30.60.60.92.3
YoY Gr.-15.8%-10.6%13.6%1.5%-104.4%NA87.5%3.3%50%-
BVPS (₹) 0.91.62.23.44.14.34.95.56.179.7
Adj Net
Profit
0.30.30.30.30.3-00.10.30.30.41
Cash Flow from Ops. 0.40.40.1-0.10.4-0.70.3-0.31-0-
Debt/CF from Ops. 00.100000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 3.3%5.5%-0.7%-25.1%
Adj EPS 5.6%6.5%42.7%50%
BVPS25.2%11.6%13.1%14.9%
Share Price 6.1% 26.3% 33.5% -20%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
49.537.124.42218.4-0.8711.610.714.227.4
Op. Profit
Mgn %
3.53.132.62.33.72.33.33.13.78.9
Net Profit
Mgn %
2.52.42.32.62.9-0.2121.537.3
Debt to
Equity
00.1000000000
Working Cap
Days
5751656361715459527459
Cash Conv.
Cycle
-40-29-36-26-1321323192635

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Unjha Formulations Ltd.

Standalone Consolidated
TTM EPS (₹) 2.3 -
TTM Sales (₹ Cr.) 14 -
BVPS (₹.) 9.7 -
Reserves (₹ Cr.) - -
P/BV 2.60 -
PE 11.01 -
From the Market
52 Week Low / High (₹) 19.99 / 35.18
All Time Low / High (₹) 1.00 / 39.00
Market Cap (₹ Cr.) 11.3
Equity (₹ Cr.) 4.5
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Unjha Formulations:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Unjha Formulations - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Unjha Formulations

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales10.3712.2411.3011.4210.609.9614.1613.1518.5013.86
Operating Expenses 1011.8610.9511.1210.359.5913.8412.7217.9213.36
Manufacturing Costs1.361.821.541.901.941.862.271.031.200.53
Material Costs7.679.118.517.837.366.7310.4810.4515.2811.17
Employee Cost 0.260.300.350.420.440.370.460.510.590.62
Other Costs 0.710.640.560.970.610.630.630.720.851.03
Operating Profit 0.360.380.340.300.250.360.320.430.580.50
Operating Profit Margin (%) 3.5%3.1%3.0%2.6%2.3%3.7%2.3%3.3%3.1%3.6%
Other Income 0.080.110.040.100.260.220.190.030.010.13
Interest 0.100.100.020.010.120.170.130.060.050.01
Depreciation 0.080.090.100.090.080.080.080.080.080.10
Exceptional Items 0000000000
Profit Before Tax 0.260.300.260.300.310.330.300.330.450.52
Tax 000000.230.050.050.170.12
Profit After Tax 0.260.300.260.300.310.100.250.280.280.41
PAT Margin (%) 2.5%2.4%2.3%2.6%2.9%1.0%1.8%2.1%1.5%2.9%
Adjusted EPS (₹)0.60.70.60.70.70.20.60.60.60.9
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 0.650.941.211.511.811.922.172.452.733.14
Share Capital 4.484.484.484.484.484.484.484.484.484.48
Reserves -3.83-3.54-3.27-2.97-2.67-2.56-2.31-2.03-1.75-1.34
Minority Interest0000000000
Debt00.0500000000
Long Term Debt00.0500000000
Short Term Debt0000000000
Trade Payables2.282.792.752.101.861.601.250.942.041.17
Others Liabilities 0-000.050.040.010.040.020.160.25
Total Liabilities 2.933.783.963.653.723.533.453.414.934.56

Fixed Assets

Gross Block3.703.984.024.064.164.234.254.354.464.63
Accumulated Depreciation2.672.762.862.943.023.103.183.263.343.43
Net Fixed Assets 1.031.221.161.121.141.121.071.101.121.20
CWIP 0000000000
Investments 0000000000
Inventories0.551.161.020.550.481.151.071.141.261.03
Trade Receivables0.810.650.781.341.150.980.701.051.611.51
Cash Equivalents 0.190.340.490.650.940.170.430.010.870.64
Others Assets 0.350.400.51-000.110.190.120.070.17
Total Assets 2.933.783.963.653.723.533.453.414.934.56

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 0.410.390.14-0.120.39-0.700.28-0.261.03-0.04
PBT 0.260.300.260.300.310.100.250.330.450.52
Adjustment 0.190.190.120.100.200.250.210.130.130.07
Changes in Working Capital 0.070-0.23-0.510.01-0.89-0.05-0.670.49-0.5
Tax Paid 0000000-0.05-0.05-0.14
Cash Flow From Investing Activity -0.02-0.280.060.04-0.10-0.06-0.02-0.10-0.11-0.18
Capex -0.02-0.280.060.04-0.10-0.06-0.02-0.10-0.11-0.18
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity -0.400.05-0.050.23000-0.06-0.05-0.01
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 00.05-0.050000000
Interest Paid 0000000-0.06-0.05-0.01
Dividend Paid 0000000000
Others -0.40000.23000000
Net Cash Flow -0.010.150.150.160.29-0.770.26-0.420.86-0.23

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)89.7552.4831.1824.2218.575.5512.3512.2210.7213.88
ROCE (%)73.767.6132.1525.4125.5726.821.1316.7619.5318.11
Asset Turnover Ratio3.333.652.9232.882.754.063.834.432.92
PAT to CFO Conversion(x)1.581.30.54-0.41.26-71.12-0.933.68-0.1
Working Capital Days
Receivable Days26222334433922242641
Inventory Days23263525183029312430
Payable Days114101119113989450383652

Unjha Formulations Ltd Stock News

Unjha Formulations Ltd FAQs

The current trading price of Unjha Formulations on 05-Dec-2025 12:11 is ₹24.98.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Unjha Formulations stood at ₹11.29.
The latest P/E ratio of Unjha Formulations as of 04-Dec-2025 is 11.01.
The latest P/B ratio of Unjha Formulations as of 04-Dec-2025 is 2.60.
The 52-week high of Unjha Formulations is ₹35.18 and the 52-week low is ₹19.99.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Unjha Formulations is ₹14.03 ( Cr.) .

About Unjha Formulations Ltd

Unjha Formulations (U-For), incorporated in 1987, is the sister concern of Urvesh Psyllium Industries Limited. U-For is the pharmaceuticals manufacturing unit, which is going to various category of formulation like tablet, capsule, oral liquids, injectables (SVP) and powder section to manufacture ayurvedic as well as allopathy products.

Fibron Powder & Fibron Sugar Free Powder are the branded ayurvedic products of the company, based on psyllium husk. The products met with an overwhelming success in our domestic market. The products mainly caters to somewhat sophisticated market segment who is conscious about their health and at the same time are very particular about various flavour like Orange, Lemon, Lime & Mango taste of the product.

Fibron Powder & Fibron SF powder offer excellent value for the money. Speed U - for could able to promote Fibron Powder & Fibron Powder SF at a most competitive price without sacrificing on quality mainly because their sister concern unit Urvesh Psyllium Industries Ltd. is one of the largest raw material supplier and processor of plyllium in the world. It may be important to note here that even Glaxo India Ltd, Proctor & Gamble, Nicholas Piramal India Ltd are the company's most valued costumers.

The company has entered into an agreement with Nicholas Piramal India for sale of Isabgol Husk based product `Tybogel` and Morepen Laboratories for sale of Dr.Mopren Sat Isabgol.

Urvesh Psyllium Industries Limited is the leading processor and exporter of Psyllium Husk & Powder in India.The company is in this line of business since last 52 years (i.e. from 1949). Initially it processed and supplied Psyllium products in local market but, looking to the worldwide demand, in 1966 it started to export Psyllium Products in the name of Rajendra Brothers. Later on with the increase of demand from overseas buyers there rose a need to expand the business, and thus Urvesh Psyllium Industries was formed in 1985, which later on was converted into a Limited Company in the year 1995.

Product range of the company includes:

  • Fibron Powder
  • Fibron Sugar Free Powder
  • Psyllium Capsules

Achievements/ recognition:

  • GMP & ISO:9001-2000 certified unit.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×